Shankar Ramaswamy, MD, the cofounder, chairman, and CEO of Kriya Therapeutics, discussed the company’s goal of bringing gene therapy to a much broader population of patients.
Shankar Ramaswamy, MD
Advertisement
Articles by Shankar Ramaswamy, MD
The cofounder, chairman, and CEO of Kriya Therapeutics discussed the company’s goal of bringing gene therapy to a much broader population of patients.
Advertisement
Latest Updated Articles
Shankar Ramaswamy, MD, on Bringing Gene Therapy to Common DiseasesPublished: May 13th 2024 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
